127 related articles for article (PubMed ID: 14169223)
1. CIRCADIAN VARIATION OF SERUM ACID PHOSPHATASE IN PROSTATIC CANCER.
DOE RP; MELLINGER GT
Metabolism; 1964 May; 13():445-52. PubMed ID: 14169223
[No Abstract] [Full Text] [Related]
2. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES.
SCHIRMER HK; RICHARDS GJ
J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206
[No Abstract] [Full Text] [Related]
3. [THE CHANGES INDUCED IN SERUM ACID PHOSPHATASE (TYPE II) BY CHLORPROMAZINE AND THE BEHAVIOR OF PROSTATE PHOSPHATASE].
KUSCH T; RINK D
Acta Biol Med Ger; 1963; 11():480-4. PubMed ID: 14115441
[No Abstract] [Full Text] [Related]
4. THE TREATMENT OF METASTATIC PROSTATIC CANCER WITH DITHIZONE (DIPHENYLTHIOCARBAZONE).
MACKENZIE AR; BHISITKUL IP; WHITMORE WF
Invest Urol; 1963 Nov; 1():229-37. PubMed ID: 14102153
[No Abstract] [Full Text] [Related]
5. CLINICAL IMPROVEMENT FOLLOWING ESTROGENIC THERAPY IN A CASE OF PRIMARY ADENOCARCINOMA OF THE SEMINAL VESICLE.
RODRIGUEZKEES OS
J Urol; 1964 Jun; 91():665-70. PubMed ID: 14172256
[No Abstract] [Full Text] [Related]
6. [POSSIBILITIES OF "GUIDED" ENDOCRINE-SURGICAL TREATMENT IN CANCER OF THE PROSTATE].
GIANNONI R; ZINI S; MARCELLI G
Arch Ital Urol; 1964 Apr; 36():423-40. PubMed ID: 14146744
[No Abstract] [Full Text] [Related]
7. [ORCHIECTOMY IN THE TREATMENT OF PROSTATIC CANCER].
PAVONE M
Urol Int; 1965; 19():19-29. PubMed ID: 14295211
[No Abstract] [Full Text] [Related]
8. [ENDOCRINE TREATMENT OF PROSTATIC CANCER].
DE VOOGT HJ
Jaarb Kankeronderz Kankerbestrijd Ned; 1963; 13():111-26. PubMed ID: 14182736
[No Abstract] [Full Text] [Related]
9. A NEW PITUITARY-INHIBITING COMPOUND IN THE TREATMENT OF PROSTATIC CANCER.
NYLANDER G; TERNER N
Urol Int; 1964; 17():129-45. PubMed ID: 14168016
[No Abstract] [Full Text] [Related]
10. Studies on prostatic cancer I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate by Charles Huggins and Clarence V. Hodges.
Glina S; Rivero MA; Morales A; Morgentaler A
J Sex Med; 2010 Feb; 7(2 Pt 1):640-4. PubMed ID: 20492413
[No Abstract] [Full Text] [Related]
11. EFFECT OF CASTRATION IN MAN UPON BLOOD SEDIMENTATION RATE, HEMATOCRIT AND HEMOGLOBIN.
HAMILTON JB; BUNCH LD; MESTLER GE; IMAGAWA R
J Clin Endocrinol Metab; 1964 Jun; 24():506-11. PubMed ID: 14187289
[No Abstract] [Full Text] [Related]
12. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.
Huggins C; Hodges CV
J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923
[No Abstract] [Full Text] [Related]
13. Immunoreactive prostatic acid phosphatase in prostatic cancer: diagnosis and followup of patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1985 Jun; 133(6):979-82. PubMed ID: 3999224
[TBL] [Abstract][Full Text] [Related]
14. TREATMENT OF CARCINOMA OF THE PROSTATE. A STUDY OF 128 FOLLOW-UP CASES.
PERTTALA Y
Ann Chir Gynaecol Fenn; 1964; 53():241-51. PubMed ID: 14163877
[No Abstract] [Full Text] [Related]
15. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate.
Huggins C; Hodges CV
CA Cancer J Clin; 1972; 22(4):232-40. PubMed ID: 4625049
[No Abstract] [Full Text] [Related]
16. Unpredictable fluctuations in serum acid phosphatase activity in prostatic cancer.
Brenckman WD; Lastinger LB; Sedor F
JAMA; 1981 Jun; 245(24):2501-4. PubMed ID: 7230488
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic cancer: indications for hormone therapy].
Bruntsch U; Gallmeier WM
MMW Munch Med Wochenschr; 1979 Mar; 121(9):300-2. PubMed ID: 85258
[No Abstract] [Full Text] [Related]
18. [RESULTS OF CHANGES IN THE HORMONAL MILIEU RELATED TO RADIATIONS IN THE TREATMENT OF ADVANCED CERVICAL CANCER].
MONTANOISLAS G; DIAZPERCHES R; LOURDES FLORES
Rev Med Hosp Gen (Mex); 1964 Aug; 27():509-27. PubMed ID: 14197535
[No Abstract] [Full Text] [Related]
19. PROSTATIC CANCER OF A YOUNG PERSON WITH PRIMARY HYPOGONADISM.
NISHIMURA R; KONDO I; OYAMATSU T
Yokohama Med Bull; 1964 Apr; 15():63-70. PubMed ID: 14166645
[No Abstract] [Full Text] [Related]
20. URINARY HYDROXYPROLINE EXCRETION IN METASTATIC CANCER OF BONE.
Platt WD; Doolittle LH; Hartshorn JW
N Engl J Med; 1964 Aug; 271():287-90. PubMed ID: 14161766
[No Abstract] [Full Text] [Related]
[Next] [New Search]
